3Pembrolizumab

Paola López-Marte1, Bárbara Rosado-Carrión2

  • 1University of Puerto Rico, School of Medicine, Division of Gastroenterology Research, San Juan, Puerto Rico.

PubMed
概括

作为检查点抑制剂的 pembrolizumab 有效治疗无法切除的癌症,但可能导致严重的肝损伤. 这一案例凸显了迅速识别和管理这种免疫疗法引起的免疫媒介性肝损伤的迫切需要.